Status:
UNKNOWN
Comparison of Anterior Corneal Optical Aberration Induced by CK and Hyperopic LASIK
Lead Sponsor:
Wang Hongxia
Collaborating Sponsors:
Tianjin Eye Hospital
Conditions:
Refractive Error
Eligibility:
All Genders
40+ years
Brief Summary
Conductive keratoplasty (CK) had shown to be a safe and effective procedure for the treatment of low to moderate hypeopia. It had been approved by the U.S. Food and Drug Administration (FDA) to treat ...
Detailed Description
To investigate anterior corneal optical higher order aberration (HOA) induced by conductive keratoplasty (CK) and laser in situ keratomileusis (LASIK). 69 eyes with hyperopia or presbyopia were enroll...
Eligibility Criteria
Inclusion
- age of over 40 years old (yrs)
- stable refraction
- planned to induce a myopic shift
Exclusion
- age of less than 40 years old (yrs)
- significant systemic illnesses
- congenital myopia,
- media opacity uveitis
- glaucoma
- intraocular surgery refractive surgery
- neurologic diseases
- retinal disease
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04676620
Start Date
December 1 2020
End Date
December 1 2021
Last Update
December 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Guanghua Integrated Traditional Chinese and Western Medicine Hospital
Shanghai, Shanghai Municipality, China, 200052